| Description |
1 online resource (131 pages) |
|
text rdacontent |
|
computer rdamedia |
|
online resource rdacarrier |
| Bibliography |
Includes bibliographical references (pages 71). |
| Contents |
Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN. |
| Summary |
Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences (NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop."--Publisher's description. |
| Note |
Description based on print version record. |
| Subject |
United States. Institutes of Health. National Center for Advancing Translational Sciences. Cures Acceleration Network.
|
|
Drug monitoring.
|
|
Drug development -- United States.
|
|
Drugs -- United States -- Design.
|
|
Pharmaceutical industry -- United States -- Quality control.
|
| Genre/Form |
Electronic books.
|
| Added Author |
Olson, Steve, 1956- contributor.
|
|
Claiborne, Anne B., contributor.
|
|
National Institute of Medicine (U.S.). Board on Health Sciences Policy, issuing body.
|
| Added Title |
Accelerating the development of new drugs and diagnostics |
| Other Form: |
Print version: Institute of Medicine (U.S.). Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary. Washington, District of Columbia : National Academies Press, [2012] xvi, 115 pages ; 23 cm 9780309261166 (OCoLC)ocn811963294 (DLC)10863714 |
| ISBN |
9780309261166 (pbk.) |
|
0309261163 (pbk.) |
|
9780309261173 (electronic bk.) |
|
